GEN
Gen Digital Inc.
GEN has lower modeled downside risk, despite its lower overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over GEN overall, supported by stronger valuation and stronger modeled upside.
GEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
GEN's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
GEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $16.34 | -45% |
| Forward | 9.5x | $29.69 | — |
| Current | 15x | $29.69 | — |
| Fair | 18x | $35.76 | +20% |
| Expensive | 28x | $54.70 | +84% |
Historical ranges are pointers, not guarantees.
GEN's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over GEN in the historical PE scenario, which offers more potential upside but is not a forecast.
GEN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for GEN, with profitability improving.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.
GEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.12 | +58% |
| Q3 2026 | $1.98 | +118% |
| Q2 2026 | $1.71 | +78% |
| Q1 2026 | $1.57 | +52% |
| Q4 2025 | $0.96 | -6.8% |
| Q3 2025 | $0.91 | -8.1% |
| Q2 2025 | $0.96 | 0% |
| Q1 2025 | $1.03 | +7.3% |
| Q4 2024 | $1.03 | -53% |
GEN's earnings per share have fallen from their peak: $1.98 over the past year, against $6.20 in mid-2020.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over GEN on earnings, with more consistent year-over-year improvement.
GEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +6.3% |
| Q1 2026 | $1.3B | +27% |
| Q4 2025 | $1.2B | +26% |
| Q3 2025 | $1.2B | +25% |
| Q2 2025 | $1.3B | +30% |
| Q1 2025 | $1B | +4.4% |
| Q4 2024 | $986M | +3.7% |
GEN's revenue has grown year over year every quarter since early 2021: $1.4B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +1.1 points |
| Q2 2026 | 33% | -2.3 points |
| Q1 2026 | 63% | +21 points |
| Q4 2025 | 35% | -3 points |
| Q3 2025 | 36% | -5.4 points |
| Q2 2025 | 35% | -7.7 points |
| Q1 2025 | 41% | -0.1 points |
| Q4 2024 | 38% | +2.7 points |
GEN's operating margin was 37% last quarter, up 1.1 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over GEN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over GEN on profitability, with a higher operating margin.
GEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $323M | +202% |
| Q2 2026 | $430M | +6.2% |
| Q1 2026 | $476M | +1.3% |
| Q4 2025 | $535M | +68% |
| Q3 2025 | $107M | -31% |
| Q2 2025 | $405M | +55% |
| Q1 2025 | $470M | -66% |
| Q4 2024 | $318M | +3.6% |
GEN generated $1.8B in free cash flow over the past year, up 36% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over GEN on cash flow, with more consistent year-over-year improvement.
GEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -3.4% | -21M shares |
| 3 years | -6.4% | -41M shares |
| 5 years | +2% | +12M shares |
| Available history | -6.8% | -44M shares |
GEN has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $171M |
| Q2 2026 | $100M |
| Q1 2026 | $200M |
| Q4 2025 | $300M |
| Q3 2025 | — |
| Q2 2025 | $134M |
| Q1 2025 | — |
| Q4 2024 | — |
GEN spent $771M buying back its own shares over the past year, about six times what it spent the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
GEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 3.0x | Moderate |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.9x | Elevated |
| Q2 2025 | 4.1x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.8x | Elevated |
GEN's net debt is about 2.9 years of its operating earnings (EBITDA), down from 3.9 years a year ago.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over GEN on leverage, with a lower net debt burden relative to earnings.
GEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 81.3 | Overbought |
GEN's weekly RSI is 59 (neutral) and its Stochastic is 81 (overbought).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
GEN PE vs Technology Sector
| Metric | GEN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 46% below |
| PE % | 32 | 35 | 3 pts below |
GEN has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
GEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 16% above |
| 20 week MA | $27.2 | 9% above |
| 50 week MA | $25.0 | 19% above |
| 100 week MA | $26.4 | 12% above |
| 200 week MA | $24.2 | 23% above |
GEN has the edge over PLTR on trend strength, trading above more of its moving averages.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.
GEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.6 | $21.0 | -18% |
| 2021 | $21.0 | $25.9 | +23% |
| 2022 | $25.9 | $21.3 | -18% |
| 2023 | $21.3 | $22.8 | +7.1% |
| 2024 | $22.8 | $27.7 | +21% |
| 2025 | $27.7 | $27.8 | +0.4% |
| 2026 YTD | $27.8 | $29.7 | +6.9% |
GEN has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.